Loading data for ALEC — first visit, this takes a few seconds.

Alector, Inc. (ALEC)

NasdaqGS: ALEC · 实时价格 · USD

2.14

-0.13 (-5.73%)

收盘价： Sep 11, 2026, 1:01 PM

提醒

Alert

股价、关键数字和最新消息，都在这一页。

-5.73% (1D)

买价	1.59
市值	237M
营收（TTM）	13.9M
净利润（TTM）	-118M
	0.65
	-1.09
	n/a
	-2.84
市净率（TTM）	-23.82
市销率（TTM）	17.08
财报日期	Nov 5, 2026

卖价	2.76
成交量	3,780,786
20日均量	1,048,762
开盘价	2.22
前收盘价	2.27
日内区间	2.00 - 2.24
52周区间	1.09 - 3.40
分析师	n/a
目标价	n/a
分红	n/a
除息日	n/a

关于 ALEC

Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases; AL137, an anti-amyloid beta antibody paired in preclinical development for the potential treatment of Alzheimer's disease; and AL050, a GCase enzyme replacement...

[阅读更多]

行业 Biotechnology

板块 Healthcare

上市日期 Feb 7, 2019

员工人数 103

交易所 NasdaqGS

股票代码 ALEC

官网 https://www.alector.com

公司完整简介

财务表现

2025年，Alector的营收为21.05M，较上一年的100.56M下降-79.07%。净利润为-142.93M，增长20.06%。

财务报表

财报意外

Alector 已于 Aug 6, 2026 发布季度财报：

营收为 $3.32M 低于预期 $0, ， -57.84% 同比下滑.
每股收益为 -0.21 超出预期 0.02, ， 30.00% 同比增长.

下次财报发布时间

Alector, Inc. 的下次财报预计于 Nov 5, 2026, 盘中。
分析师预计营收为 ... 升级

股价变动原因

新闻

1月前 · Zacks

Alector (ALEC) Reports Q2 Loss, Tops Revenue Estimates

Alector (ALEC) delivered earnings and revenue surprises of +12.50% and +283.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

2月前 · BioPharma Dive

GSK ends brain drug alliance with Alector

Clinical setbacks derailed what was once a potentially $2.2 billion deal that marked GSK's return to neuroscience.

2月前 · Simply Wall St.

Alector (ALEC) Stock Faces Mixed Analyst Target Changes On Tau Therapy Readthrough

Alector’s latest update leaves the model fair value steady at US$3.10 per share, so headline price target assumptions are unchanged even as inputs inside the model continue to move. Analysts are linki...

3月前 · Simply Wall St.

How The Alector (ALEC) Investment Story Is Shifting With Tau Readthroughs And BBB Shuttle Focus

Alector’s updated analyst framework now points to a fair value move from US$2.88 to US$3.10, a modest shift that still signals a meaningful recalibration of expectations. This change is closely tied t...

4月前 · Zacks

Alector (ALEC) Reports Q1 Loss, Lags Revenue Estimates

Alector (ALEC) delivered earnings and revenue surprises of +40.00% and -65.13%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

第 1 页，共 2 页